Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Weak opioids--an educational substitute for morphine?

S Grond1, T Meuser

  • 1Department of Anaesthesiology and Operative Intensive Care, University of Cologne, Cologne, Germany.

Current Opinion in Anaesthesiology
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate-to-severe atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab.

The British journal of dermatology·2021
Same author

[Pain therapy in in-patients with cancer. Effects of a manual-based approach as guideline for pain-consulting service at a university hospital].

Deutsche medizinische Wochenschrift (1946)·2016
Same author

[Pain relief at the end of life. A genuine medical task within palliative medicine].

MMW Fortschritte der Medizin·2012
Same author

Washout of sevoflurane from the GE Avance and Amingo Carestation anesthetic machines.

Acta anaesthesiologica Scandinavica·2011
Same author

Involvement of multiple loci in quorum quenching of autoinducer I molecules in the nitrogen-fixing symbiont Rhizobium (Sinorhizobium) sp. strain NGR234.

Applied and environmental microbiology·2011

Weak opioids are recommended by the World Health Organization for cancer pain relief. While less potent than other analgesics, they offer educational benefits and easier accessibility with potentially fewer side effects.

Area of Science:

  • Pain Management
  • Pharmacology
  • Oncology

Background:

  • The World Health Organization (WHO) recommends a stepwise approach to cancer pain management.
  • Weak opioids represent the second step on the WHO analgesic ladder.
  • Understanding the role and efficacy of weak opioids is crucial for effective pain control.

Purpose of the Study:

  • To evaluate the role of weak opioids in cancer pain management according to WHO guidelines.
  • To assess the benefits and limitations of weak opioids compared to other analgesics.
  • To highlight the educational and accessibility advantages of weak opioids.

Main Methods:

  • Review of World Health Organization analgesic guidelines.
  • Comparative analysis of weak opioids versus non-opioid and strong opioid analgesics.

Related Experiment Videos

  • Assessment of educational impact and availability of weak opioids.

    • Main Results:

    • Weak opioids are suggested for the second step of the WHO analgesic ladder for cancer pain.
    • They serve as effective substitutes for low-dose morphine but have lower analgesic efficacy.
    • Their use has positively impacted guideline dissemination and education.
    • Weak opioids are generally more accessible and may have a better side-effect profile.

    Conclusions:

    • Weak opioids play a significant role in the WHO's approach to cancer pain relief.
    • Further controlled long-term studies are necessary to confirm their efficacy and safety profile.
    • The educational value and accessibility of weak opioids contribute to their widespread adoption.